SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-056678
Filing Date
2024-06-27
Accepted
2024-06-27 16:23:20
Documents
14
Period of Report
2024-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0208662-8k_silo.htm   iXBRL 8-K 24194
2 FOURTH AMENDMENT TO MASTER LICENSE AGREEMENT ea020866201ex10-1_silo.htm EX-10.1 13306
  Complete submission text file 0001213900-24-056678.txt   212095

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE silo-20240626.xsd EX-101.SCH 3021
4 XBRL LABEL FILE silo-20240626_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE silo-20240626_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0208662-8k_silo_htm.xml XML 3566
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 241079593
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl
(CF Office: 04 Manufacturing)